Diagnostic News and Research

RSS

Gender influences nonmotor symptoms in early Parkinson’s

The predominant nonmotor symptoms in patients with Parkinson’s disease vary between men and women, shows an analysis of the Parkinson’s Progression Markers Initiative study.

4 Jun 2015

WuXi AppTec, Fudan University partner for genomics database system

WuXi AppTec today announced a partnership with Fudan University to bring WuXi NextCODE's world-leading population human genomics database system and integrated research and clinical solutions to the Fudan-led Collaborative Innovation Center of Genetics and Development as an enterprise partner.

4 Jun 2015

University of Chicago scientists develop new technique to accurately measure epigenetic changes

One of the most widely used tools in epigenetics research - the study of how DNA packaging affects gene expression - is chromatin immunoprecipitation (ChIP), a technique that allows researchers to examine interactions between specific proteins and genomic regions. However, ChIP is a relative measurement, and has significant limitations that can lead to errors, poor reproducibility and an inability to be compared between experiments.

4 Jun 2015

Exalenz Bioscience initiates BreathID clinical study to detect primary liver cancer

Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced the initiation of a clinical study designed to investigate its BreathID test to non-invasively detect primary liver cancer, also known as Hepatocellular Carcinoma (HCC).

4 Jun 2015

Pediatric Sepsis diagnosed in three to five hours versus two to six days data at ASM

The data presented today demonstrate that in each of the 15 confirmed candidemia pediatric patient samples in the study, T2Candida was able to accurately identify the Candida species in three to five hours compared to two to six days for blood culture...

4 Jun 2015

US Equity Holdings announces new funding to launch Aelan Cell Technologies

US Equity Holdings announced yesterday that it has secured funding to launch Aelan Cell Technologies, a biotech startup engaged in the research, discovery, development and commercialization of innovative biomedical technologies and diagnostic tools for the advancement of human health and longevity.

4 Jun 2015

Wistar Institute scientists find new biomarker that appears to be more accurate at detecting NSCLC

Survival rates for patients with lung cancer increase dramatically the earlier the disease is diagnosed, underscoring the need for effective biomarkers that can be used for detection. Now, scientists at The Wistar Institute have found a protein that circulates in the blood that appears to be more accurate at detecting non-small cell lung cancer (NSCLC) than currently available methods used for screening.

4 Jun 2015

'SpinDrops' app provides insight into the quantum properties of coupled nuclear spins

Magnetic resonance tomography (MRT) images are an important diagnostic tool. The achievable contrast depends on how well the nuclear spins that form the basis of the imaging signals can be controlled. Mathematically, the properties of nuclear spins are described by special matrices.

4 Jun 2015

Women & Infants Hospital awarded $5 million NIH grant to support COBRE for Perinatal Biology

Women & Infants Hospital of Rhode Island has recently received a nearly $5 million grant from the National Institutes of Health to support an Institutional Development Award Center of Biomedical Research Excellence for Perinatal Biology.

4 Jun 2015

New article published in Spanish Journal of Pathology highlights a rare case of Hodgkin's lymphoma

Dr. Jerónimo Forteza, Professor of Pathology and Director of the Valencian Institute of Pathology, Catholic University of Valencia "San Vicente Mártir," recently published an article in the Spanish Journal of Pathology on the case of a patient with Hodgkin's lymphoma. Medicine student Pablo Sánchez Vela performed this diagnostic work under the supervision of Dr. Forteza.

3 Jun 2015

Unfors RaySafe launches LowerMyDose.com to educate physicians, clinical staff on radiation exposure risks

For years, the radiology industry has focused on reducing, or eliminating patient exposure to radiation. Recently, the industry has shifted attention to the cumulative effect radiation exposure has over the course of a physician's career.

3 Jun 2015

Ultrasound becoming the most widely used imaging tool in medicine today

Mention "ultrasound" and most people likely will think of an image of a fetus in a mother's womb. But while providing peeks at the not-yet-born is one of ultrasound's most common applications, that's only a small part of the picture.

3 Jun 2015

CDS systems fail to identify relevant appropriateness criteria for ordering of advanced diagnostic imaging

An analysis of the use of computerized clinical decision support systems regarding orders for advanced diagnostic imaging found that the systems failed to identify relevant appropriateness criteria for the majority of orders, according to a study in the June 2 issue of JAMA.

3 Jun 2015

WHO accepts Elafibranor as generic name for GENFIT’s GFT505 drug candidate

GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces that the World Health Organization (WHO) has accepted the international non-proprietary name (INN, or generic name) Elafibranor for its leading drug candidate previously referred to as GFT505.

3 Jun 2015

Children's National Health System selects Agfa HealthCare's DR Technologies to reduce radiation dose in pediatric patients

Agfa HealthCare announced today that Children's National Health System has installed six DX-D 100 mobile DR systems and two DX-D 600 full room direct radiography (DR) suites to transition two X-ray rooms from computed radiography (CR) to DR.

3 Jun 2015

Researchers transform bacteria into 'secret agents' for detecting disease

Another step forward has just been taken in the area of synthetic biology. Research teams from Inserm and CNRS (French National Centre for Scientific Research) Montpellier, in association with Montpellier Regional University Hospital and Stanford University, have transformed bacteria into "secret agents" that can give warning of a disease based solely on the presence of characteristic molecules in the urine or blood. To perform this feat, the researchers inserted the equivalent of a computer programme into the DNA of the bacterial cells.

3 Jun 2015

Tools that help decide use of expensive imaging studies can reduce ordering of unnecessary tests

Using tools that help physicians decide whether to use expensive imaging studies such as MRI scans can help reduce the ordering of unnecessary tests, but implementation of the tools in real-world settings has many challenges, according to a new RAND Corporation study.

3 Jun 2015

Researchers develop electron density diagnostic method for medical and biological uses

The National Institutes of Natural Sciences, National Institute for Fusion Science and The University of Tokyo Graduate School of Frontier Sciences Department of Advanced Materials Science research group have developed an electron density diagnostic method for atmospheric pressure low-temperature plasma that is anticipated to be applicable for the fields of environmental protection and of medicine and biology.

3 Jun 2015

MedImmune, AstraZeneca present encouraging results from new combination-focused immuno-oncology portfolio at ASCO 2015

AstraZeneca and MedImmune, the company’s global biologics research and development arm, today presented encouraging results from their novel combination-focused immuno-oncology portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting 2015.

2 Jun 2015

Ariana Pharma joins the GastricGlycoExplorer consortium

This collaboration is carried out within the GastricGlycoExplorer consortium, a European Commission funded project. The consortium aims at discovering and developing new diagnostic signatures by characterizing the sugars that are attached to the surface of gastric tissue. "Glycomics" provides a systematic approach for studying sugars that are naturally present on cell surfaces and its application may lead to determine early markers of gastric cancer.

2 Jun 2015

Diagnostic News and Research

Gender influences nonmotor symptoms in early Parkinson’s

WuXi AppTec, Fudan University partner for genomics database system

University of Chicago scientists develop new technique to accurately measure epigenetic changes

Exalenz Bioscience initiates BreathID clinical study to detect primary liver cancer

Pediatric Sepsis diagnosed in three to five hours versus two to six days data at ASM

US Equity Holdings announces new funding to launch Aelan Cell Technologies

Wistar Institute scientists find new biomarker that appears to be more accurate at detecting NSCLC

'SpinDrops' app provides insight into the quantum properties of coupled nuclear spins

Women & Infants Hospital awarded $5 million NIH grant to support COBRE for Perinatal Biology

New article published in Spanish Journal of Pathology highlights a rare case of Hodgkin's lymphoma

Unfors RaySafe launches LowerMyDose.com to educate physicians, clinical staff on radiation exposure risks

Ultrasound becoming the most widely used imaging tool in medicine today

CDS systems fail to identify relevant appropriateness criteria for ordering of advanced diagnostic imaging

WHO accepts Elafibranor as generic name for GENFIT’s GFT505 drug candidate

Children's National Health System selects Agfa HealthCare's DR Technologies to reduce radiation dose in pediatric patients

Researchers transform bacteria into 'secret agents' for detecting disease

Tools that help decide use of expensive imaging studies can reduce ordering of unnecessary tests

Researchers develop electron density diagnostic method for medical and biological uses

MedImmune, AstraZeneca present encouraging results from new combination-focused immuno-oncology portfolio at ASCO 2015

Ariana Pharma joins the GastricGlycoExplorer consortium

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News